You have not been paying attention! We're looking for progress (and positive data) from real clinical trials, for business developments that are reasonable to expect at this stage of Pluristem's life cycle.
As far as expectations, I can assure you that I'm looking for a lot more than "BREAKEVEN"! If PLX-PAD for CLI is approved, we have a multi-billion dollar drug. Think about what that will do for the PPS! BTW, does your chart have any information on the probability of approval?? NO?? I didn't think so. I recommend that you read "SOME ARTICLE", or more than one, lots of good information available.